Rancho Cucamonga Welcomes New Director of Innovation and Technology
July 29, 2025 - 20:30
The City of Rancho Cucamonga has announced a strategic partnership with Tripepi Smith Talent Solutions to enhance its recruitment efforts for the position of Director of Innovation and Technology. Following a thorough and successful recruitment process, the city is thrilled to introduce Behrang Abadi as the new director.
Behrang Abadi comes to this role with an impressive background, bringing over 20 years of experience in technology and innovation management. His expertise encompasses a wide range of skills, including digital transformation, project management, and strategic planning. Abadi's prior positions have equipped him with the knowledge necessary to lead initiatives that will foster technological advancement within the city.
The City of Rancho Cucamonga is optimistic that Abadi's leadership will drive innovative solutions and improve technology services for residents and businesses alike. This appointment reflects the city's commitment to embracing modern technology and enhancing the overall quality of life for its community.
MORE NEWS
September 30, 2026 - 21:59
Micron Technology Tops Lofty Fiscal Q4 Goals, Guides Above ViewsMicron Technology exceeded analyst expectations for its fiscal fourth quarter, delivering results that outperformed even the most optimistic projections on Wall Street. The memory chip maker...
September 30, 2026 - 01:50
Space Force Turns to Laser Systems to Shield Launch Sites from Drone ThreatsThe U.S. Space Force is moving forward with plans to deploy laser technology as part of a broader effort to defend its launch facilities from unauthorized drones. The initiative focuses on...
September 29, 2026 - 04:58
DIU Seeks Investors in Counter-Unmanned Systems TechnologyThe Defense Innovation Unit is looking for private investors to back companies working on counter unmanned systems technology. The effort targets firms building tools to detect, track, and disable...
September 28, 2026 - 02:02
Novo Nordisk (CPSE:NOVO B) Secures Long-Acting Injectable Technology In €1.165 Billion Nanexa Licensing AgreementNovo Nordisk has entered a global licensing agreement with Swedish drug delivery company Nanexa, valued at up to 1.165 billion euros. The deal centers on Nanexa`s PharmaShell technology, a platform...